BioCentury
ARTICLE | Company News

Epitomics cancer, antibodies news

August 23, 2010 7:00 AM UTC

Epitomics spun out newco Apexigen Inc. (Burlingame, Calif.) to focus on developing and commercializing humanized mAbs to treat cancer and immune disorders. Epitomics granted Apexigen exclusive, world...